Cost-Effectiveness Analysis of a Mobile-Based Intervention for Patients with Type 2 Diabetes Mellitus

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left"> </td><td class="align_center">HbA1c control rate (%)</td><td class="align_center">Cost (CNY¥)</td><td class="align_center">CEA</td><td class="align_center">ICER</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">mHealth group</td><td class="align_center">74.6%</td><td class="align_center">1169.76</td><td class="align_center">1541.19</td><td class="align_center">−22.02</td></tr><tr><td class="align_left">Usual care group</td><td class="align_center">47.1%</td><td class="align_center">1775.44</td><td class="align_center">3769.50</td><td class="align_center"> </td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of cost-effectiveness analysis between the mHealth group and usual care group.</div>

International Journal of Endocrinology

tab3

Table 3

Table 3: Cost-Effectiveness Analysis of a Mobile-Based Intervention for Patients with Type 2 Diabetes Mellitus 